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Abstract 
 
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder that affects social 
communication skills and flexible behaviour. Developing new treatment approaches for ASD 
requires early identification of the factors that influence later behavioural outcomes. One 
fruitful research paradigm has been the prospective study of infants with a first degree 
relative with ASD, who have around a 20% likelihood of developing ASD themselves. Early 
findings have identified a range of candidate neurocognitive markers for later ASD such as 
delayed attention shifting or neural responses to faces, but given the early stage of the field 
most sample sizes are small and replication attempts remain rare. The Eurosibs consortium is 
a European multisite neurocognitive study of infants with an older sibling with ASD 
conducted across nine sites in five European countries. In this manuscript, we describe the 
selection and standardization of our common neurocognitive testing protocol. We report data 
quality assessments across sites, showing that neurocognitive measures hold great promise 
for cross-site consistency in diverse populations. We discuss our approach to ensuring robust 
data analysis pipelines and boosting future reproducibility. Finally, we summarise challenges 
and opportunities for future multi-site research efforts. 
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Introduction 
 
Autism Spectrum Disorder is a neurodevelopmental disorder characterised by 
difficulties with social communication, and the presence of restricted/repetitive behaviours 
and sensory issues (DSM-5, APA, 2013). ASD affects around 1 to 2% of children and is 
associated with lifetime healthcare costs of up to £1.5 million in the UK (Buescher et al., 
2014). Developing new ways to identify and support individuals with ASD to reach their full 
potential is thus critical. Indeed, early intervention can alter trajectories and improve 
outcomes (Dawson et al., 2010; Green et al., 2017; Pickles et al., 2016). However, although 
parents first report experiencing concerns in infancy or toddlerhood (Herlihy et al., 2013), the 
average age of diagnosis of ASD remains around 5 years in some countries (Brett et al., 
2016). One issue is a lack of understanding of the earliest manifestations of ASD, which 
limits our ability to design novel early interventions and identify children whom they may 
benefit. Further, in order to optimise early identification and treatment we need to understand 
the mechanisms that underlie the emergence of ASD symptoms in early development.  
Prospective longitudinal studies of infants with an older sibling with ASD (‘infant 
siblings’) allow us to study symptoms as they emerge (Jones et al., 2014; Szatmari et al., 
2016). ASD is a highly heritable condition, with genetic contributions to phenotypic variation 
of 64-91% (Tick et al., 2016). Over the last decade, a number of prospective studies have 
followed infant siblings to the age of 3, when a diagnosis of ASD can be made with robust 
reliability (Woolfenden et al., 2012). Such studies have identified an ASD recurrence rate of 
around 20% (Ozonoff et al., 2011), with a further 20% of children experiencing sub-threshold 
symptoms or other developmental difficulties (Charman et al., 2017; Messinger et al., 2013). 
This research design is a powerful method of examining the pattern of infant development 
associated with a later diagnosis of ASD.  
One of the major strengths of the infant sibling design (relative to retrospective 
approaches such as analysis of home videos or parent report) is the ability to assess 
neurocognitive development using infant-friendly methods such as eyetracking, 
electroencephalography (EEG) and functional near-infrared spectroscopy (fNIRS). Such 
techniques allow us to measure changes in brain and cognitive development that may occur 
before the clear emergence of behavioural signs of ASD. Indeed, early reports from infant 
sibling studies have suggested a number of promising avenues for further work (Jones et al., 
2014; Szatzmari et al., 2016). For example, studies using EEG and eyetracking have 
indicated that infants with later ASD show reduced engagement with faces by 6 months in 
some contexts (Jones et al., 2016; Jones & Klin, 2015; Chawarska et al., 2013; Shic et al., 
2014; Klin, Schultz & Jones, 2015), whilst overt social behaviour is broadly still typical 
(Ozonoff et al., 2010). Novel methodologies like fNIRS suggest there may be reduced 
specialisation of core social brain regions in infants with later ASD (Lloyd Fox et al., 2017). 
Atypicalities are not limited to the social domain. Slower disengagement of visual attention 
around the first birthday has emerged as a consistent finding across multiple reports (Elison 
et al., 2013; Elsabbagh et al., 2013; Zwaigenbaum et al., 2005). Disruptions have been 
observed in very low-level processes such as the strength of the pupil response to light 
measured with eyetracking (Nystrom et al., 2018). Strengths have also been identified; for 
example, eyetracking measures suggest that infants with later ASD may be better at 
identifying a target amongst distractors (Gliga et al., 2015; Cheung et al., 2016). A range of 
alterations in EEG power and connectivity have also been identified from early infancy, 
broadly suggesting altered trajectories of functional brain development (e.g. Bosl et al., 2011; 
Gabard-Durnam et al., 2015; Righi et al., 2014; Tierney et al., 2012; Levin et al., 2017; 
Orekhova et al., 2014). Early evidence thus points to the relevance of both socially-relevant 
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brain processes and early domain-general differences as critical areas of study in infant 
sibling designs.  
Whilst promising, progress in understanding early functional brain development in 
ASD has been hampered by relatively small sample sizes (as in developmental psychology 
more broadly, though the ManyBabies project is a notable exception here; Frank et al., 2018). 
Further, there have been few attempts to examine the robustness of effects across contexts 
and cultures. Thus, there is a critical need for large-scale data pooling efforts and the 
integration of data from infants with a wide range of demographic and cultural backgrounds.  
One advance in yielding robust and clinically-relevant insights into infant siblings at the 
behavioural level has been the efforts of the Baby Sibs Research Consortium (BSRC) to pool 
behavioural, clinical and questionnaire data across multiple predominately North American 
groups. This data pooling effort has led to papers on the ASD recurrence rate (Ozonoff et al., 
2011); prevalence of the Broader ASD Phenotype (Messinger et al., 2013); clinically-relevant 
difficulties beyond ASD experienced by infant sibs (Charman et al., 2017); sex differences in 
the expression of ASD symptoms (Messinger et al., 2015); and stability of diagnosis from 18 
to 36 months (Ozonoff et al., 2015). The BSRC illustrates the power of pooling data across 
multiple sites in yielding insights into early development in ASD. However, since the BSRC 
focuses predominantly on pooling behavioural measures, the potential for multisite studies to 
answer broader questions about underlying neurocognitive mechanisms remains unexplored.  
Large samples will allow us to ask more nuanced questions about the relations 
between different neurocognitive markers. For example, preliminary evidence from one 
relatively small cohort suggests that elevated disengagement times and altered gaze following 
make additive contributions to later ASD (Bedford et al., 2014);  and that there may be sex 
differences in the relation between infant neurocognitive markers and later symptoms 
(Bedford et al., 2016). However, larger samples are needed to rigorously test these models. 
Further, larger samples will allow us to take seriously the mounting evidence that ASD does 
not reflect a unitary construct and may require stratification into more homogeneous 
etiological subgroups (Loth et al., 2015, 2017). Most studies to date have reported main 
effects of categorical diagnostic outcome , with far more limited data on individual-level 
prediction (though see Bussu et al., 2018). The latter is important not just for clinical utility, 
but also for determining the extent to which results represent a common path to ASD or are 
specific to a subgroup of individuals who may share a particular developmental etiology. 
Large prospective studies of infants with higher familial likelihood of developing ASD may 
allow us to subgroup types of ASD by developmental profiles, which may be the point at 
which varied etiologies are most clearly identified. Of note, we choose to use the term 
‘likelihood’ rather than the more commonly used ‘risk’ to reflect the preferences of the 
autistic community (Fletcher-Watson et al., 2017). 
Whilst data pooling efforts for behavioural measures are advanced, there are very few 
examples of attempts to prospectively collect neurocognitive data on a large scale. One 
exception is the Infant Brain Imaging Study (IBIS http://www.ibis-network.org/), a multisite 
US neuroimaging study which has produced a range of groundbreaking papers on structural 
brain development in infant siblings (e.g. Hazlett et al., 2017; Elison et al., 2013; Wolff et al., 
2015). For example, data from the IBIS study suggests that ASD is associated with a pattern 
of early region-specific cortical hyper-expansion (Piven et al., 2017), and machine-learning 
approaches suggest that these observations have a degree of predictive validity at the 
individual level (Hazlett et al., 2017). These studies indicate the power of data pooling across 
multiple sites for generating insights into brain structure and function, as well as behaviour. 
However, MRI-based measures are expensive and can be very challenging to acquire in 
young infants. Their scalability as tools for early identification and their ability to identify 
features that could provide targets for intervention is thus a challenge, particularly as we 
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move to global health contexts. Further, it is very difficult to record MRI in awake infants. 
Since social interaction is a core domain of difficulty in ASD, measures of functional brain 
development that can be recorded in more naturalistic settings are also critical for 
understanding the disorder. Multisite studies of neurocognitive development in infants with a 
heightened likelihood of developing ASD tested across a range of cultures and contexts are 
necessary to move the field forward. 
Here, we describe the formation of a common neurocognitive protocol that we have 
deployed across 9 sites in 5 European countries through the Eurosibs consortium. Eurosibs is 
a European multisite study involving investigators in the UK (Birkbeck College, London; 
King’s College London, University of Cambridge), Sweden (Karolinska Institute, Uppsala 
University), Belgium (Ghent University), Poland (University of Warsaw), and the 
Netherlands (Radboud University Nijmegen, Utrecht University).  We briefly outline how we 
selected and implemented a rigorously standardised experimental protocol at each site; how 
we standardised lab practices to maximise comparability; and how we designed analytic 
pipelines for pooling data across different collection systems. We present example data 
quality metrics from the subset of network sites who currently have sufficient sample sizes 
for each measure to illustrate the strengths of our approach to harmonisation. At this stage we 
refer to sites anonymously with letter codes to prevent premature consideration of specific 
cultural or linguistic factors that could affect our data because the study was not designed for 
this purpose; rather, we focus on identifying where measures appear consistent across sites. 
We further present experimental data from one example paradigm (the gap-overlap task) to 
test our ability to robustly measure core neurocognitive metrics across sites. We focus on this 
paradigm because slowed disengagement at 12- to 14-months has been related to later autism 
across three small previous studies (Elsabbagh et al., 2013; Elison et al., 2013; Zwaigenbaum 
et al., 2005); thus, it is a core target for our research program. Finally, we discuss our 
approach to minimising publication bias and the ‘file drawer’ problem, pitfalls and strengths, 
and our plans for building on our consortium work in the future. We hope that our study will 
provide an initial roadmap for other investigators interested in conducting multisite 
neurocognitive studies of early human development. 
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Methods 
 
Participant information 
Infants in the High-Likelihood group (HL) had an older sibling with a community clinical 
diagnosis of Autism Spectrum Disorder (ASD) as confirmed by clinician judgment. Infants in 
the Low-Likelihood (LL) group had at least one older sibling with typical development (as 
reported by the parent) and no first-degree relatives with ASD. Further information about 
clinical ascertainment can be found in S1.0. Infants were primarily enrolled at 5 or 10 
months; a few infants were enrolled at 14 months. At each age point, the preferred testing 
window was +/-1 month from the relevant birthday; if this was not possible, we allowed 
testing up to +2 months to minimise data loss. In the present manuscript, we report available 
data metrics from a subset of infants tested at 5, 10 and 14 months. Some sites did not collect 
EEG or eyetracking data in infancy and hence are not included in the present report. Other 
sites only collected particular data streams at particular time-points (e.g. Site E did not collect 
infant EEG from Eurosibs tasks; site D only collected EEG at 5 months). Because data 
collection is ongoing, we have included all data uploaded to the central database and 
subjected to quality control assessment before February 2018 in this preliminary report. This 
data is thus intended to illustrate our protocol and procedures, and not to represent a finalised 
report on the cohort. Thus, all metrics are presented collapsed across likelihood group to 
avoid compromising future analysis plans, which are preregistered and embargoed until our 
defined data freeze points (see Discussion). Measures analysed, sample sizes and likelihood, 
gender and age profiles of samples at each site are shown in Tables 1a and b. Of note, there 
were significant differences between sites in the proportion of high and low likelihood infants 
in the sample (X2= 13.6, p = 0.009), with site E having a relatively even balance (due to study 
design) whilst most sites had a majority of high likelihood infants. There were also 
significant age differences between sites (max. hp2 = 0.19), although numerically mean 
differences were small (Table 1b). 
 
<<INSERT TABLES 1a and 1b ABOUT HERE>> 
 
 
Ethics  
Protocols were approved by the relevant committee at each site and were conducted in 
accordance with the Declaration of Helsinki and the American Psychological Association. 
Broadly, each study was conducted guided by a consistent set of principles. These included 
placing the infant’s wellbeing at the centre of our focus at all times. Infants were always with 
their parent or caregiver who provided informed consent before the study began, and testing 
could be stopped or interrupted and rescheduled at any time if the infant became fussy or the 
caregiver did not want to continue. Protocols were designed to maximise infant comfort, and 
be interesting and engaging. Data protection and confidentiality are paramount, which shapes 
our approach to data sharing within and outside the consortium. Briefly, personal data is 
stored securely at each individual site; pooled data is pseudonymised and housed in a 
password-protected encrypted centralised database. Access is fully audited, and to ensure 
data security is governed by a management structure that includes cross-site Quality Control 
groups, modality-specific Core Analysis groups, and the Eurosibs management board (see 
Discussion and S1.2). 
 
Protocol  
Our full phenotypic protocol is shown in Table S1. This includes a range of phenotypic 
questionnaires that were translated by publishers (or translation services for in-house 
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measures) and administered in the native language at each site.  Where possible, a full 
adaptation process with translation and back-translation consulted by the authors was 
undertaken (see Bolte et al., 2016 for an extended discussion of access to standardised 
measures in early autism research in Europe). Metrics were then harmonised within a central 
database. We have depicted cross-site data from two selected measures that are usually 
interpreted with respect to US norms; the parent-report Vineland (Sparrow, Bella, Cicchetti, 
Harrison & Doll, 1984) and the examiner-administered Mullen Scales of Early Learning 
(MSEL; Mullen, 1995). These were selected for compatibility with the BSRC consortium to 
allow future global data pooling; there were no available behavioural instruments normed in 
all the countries in our consortium. Site A used the US versions of the Mullen and Vineland. 
Sites B, C, and E used informal translations of the MSEL. Site D used the US version of the 
Mullen (including norms), with items requiring the examiner to speak translated informally 
into the local language by experienced clinicians and members of the testing team.  Site E 
used a translated 72-item form of the Vineland survey questionnaire by E.M. Scholte & I.A. 
Van Berckelaer-Onnes, 2008 (based on S.S. Sparrow, A.S. Carter, & D.V Cicchetti) 
published and distributed by PITS B.V. Leiden, The Netherlands, with permission of the 
authors.  At Sites B, C, and D the Vineland was administered as an interview by a trained 
clinician or researcher at the infant timepoints due to lack of availability of an officially 
translated version. Sites B and C did this based on a manual translated by S. Breider en A. de 
Bildt (2014, Leiden University); Site D used an in-house translation. The interview version of 
the Vineland was generally done in person during the visit, with a few exceptions conducted 
over the phone. Of note, all sites that used informal translations purchased the equivalent 
number of copies of the original forms from the publisher. 
Neurocognitive measures were selected on the basis of preliminary evidence that they 
provided robust data quality, and that they were likely to be informative within the infant sib 
design (see below). We have demonstrated that many of our measures show good to high 
test-retest reliability (Cousijn et al., 2017; Hessels et al., 2016; Wass & Smith, 2014). We 
selected tasks that each yielded multiple informative metrics for analysis (rather than more 
‘cognitive’ tasks that might provide one dependent variable). This allowed us to collect a 
denser quantity of information within a shorter time-window. In addition, some infants 
participated in an MRI and NIRS protocol at 5 months; because this was a relatively small 
proportion of the cohort, these datasets are not discussed here. Sites were required to 
administer tasks in a certain order within a testing modality (e.g. in the EEG session, children 
were assigned to view the social and non-social videos in a set order, specified in the 
scripting framework), but were free to adopt more flexibility in terms of when each modality 
was collected during the visit. This was essential since (for example) some families travelled 
longer distances than others, and so testing was split across more than one visit in some 
cases. However, where possible sites collected the EEG and eyetracking sessions after the 
child had napped (or when they first came into the lab) to minimise fatigue. We collected 
information about order on a Behavioural Observation Sheet. 
 
Mullen Scales of Early Learning: The Mullen Scales for Early Learning (Mullen, 1995) are 
designed to measure cognitive abilities from birth to 68 months of age across 5 domains 
(Visual Reception [VR], Fine Motor [FM], Receptive Language [RL], Expressive Language 
[EL], and Gross Motor [GM]). Standard scores are calculated based on US norms. For 
harmonisation, we created a set of age-specific demonstration videos with scoring (in 
English) that were used in initial training at every site. All primary testers in charge at each 
site speak fluent English, as is common in European academia.  
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We hosted a series of in-person meetings, webinars and phone calls with core team members 
in which we went through the manual on an item by item basis and discussed administration 
and scoring. We discussed any queries arising during the course of the study at our monthly 
cross-site phone calls.  Scores were reviewed for impossible values or missing items and 
corrected. Where subsequent training was required at an individual site (e.g. because a new 
PhD student joined the team), the primary testers would select examples of ‘good 
administration’ in the native language to complement the cross site training video. The new 
tester would watch these plus the original training videos; they would then watch live 
administrations at the site in question; read the manual and translation thoroughly; and then 
be observed for their first minimum three administrations with feedback. Administration 
would continue to be monitored by primary testers throughout the study. 	
Vineland Adaptive Behaviour Scale: The Vineland Adaptive Behaviours Scale-II (Sparrow et 
al., 2005; Sparrow et al., 1984) caregiver/ parent survey is a questionnaire that assesses 
adaptive behaviours in individuals from birth through 90 years of age across four key 
domains (communication, socialization, daily living skills, motor skills). Possible scores are 
based on how often the child performs the relevant activity, and include 2 (usually), 1 
(sometimes or partially), 0 (never), NO (no opportunity), or DK (do not know). Again, 
standard scores are computed based on US norms.  Sites A and E administered the 
questionnaire format because they did not have the resources or time to administer the 
Vineland as an interview at the infant testing points. The primary focus of our study was the 
neurocognitive measures, and so we chose to prioritise those batteries for the time the infant 
and parent were in the lab. Further, Site A had been using the Vineland questionnaire format 
for several years, meaning that continuing to use that measure could allow data pooling 
(Bussu et al., 2018). To ensure fidelity, in addition to the instructions to parents provided on 
the official version of the survey, sites provided parents with clear instructions about where to 
start and stop for each section. Irrelevant sections of the form (e.g. for younger or older 
infants) were crossed out. Forms were checked by trained research assistants for errors when 
the questionnaire was returned (e.g. not following the stopping rules correctly, missing items) 
and the parent was asked about these items in the visit.  Due to lack of availability of an 
official translation for the questionnaire version, at Sites B, C and D administration was done 
in interview format by a trained clinician or research assistant. Sites entered data through the 
Vineland Assist, which provides a further level of automated data quality checking (e.g. 
whether ceiling has been correctly identified). Finally, we had a centralised quality control 
(QC) process that included double-entry and checking and correcting for impossible values 
and missing data.   
 
Spontaneous EEG: Our core EEG task involved presentation of naturalistic videos with social 
and nonsocial content (Jones et al., 2015). The video stimuli were made up of women singing 
nursery rhymes (Social; see S1.3 for further details) or toys spinning (Non-social). The Non-
social video comprised of 6 consecutive toys spinning, each spinning toy was presented for 
10 seconds. The duration of each video condition (Social vs Non-social) was 60 seconds, and 
each condition was presented a maximum of 3 times, so infants received a total of 3 minutes 
per condition. The order of video presentation (Social or Non-social presentation first) was 
counterbalanced across participants.  In the present paper we report metrics of data quality 
and completion rates from our EEG protocol. 
 
Eyetracking: Four key eyetracking tasks were included in the full protocol (see S1.4 for 
further details). In the present manuscript, we present metrics of data quality taken across the 
battery. In addition, we report the core metrics extracted from the Gap task as an example of 
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our full processing pipeline. The Gap task (adapted from Johnson, Posner & Rothbart, 1991, 
Elsabbagh et al., 2013, Landry & Bryson, 2004) was selected because attention-shifting has 
shown predictive value for later ASD across three samples (Elsabbagh et al., 2013; 
Zwaigenbaum et al., 2005; Elison et al., 2013). Our operationalisation is a gaze-contingent 
paradigm that measures visual-attention shifting from a central to a peripheral stimulus in one 
of three conditions; i) Gap, in which the central stimulus disappears 200ms before the 
appearance of the peripheral target; ii) Baseline, in which the central stimulus disappears 
simultaneously with the appearance of the peripheral target; iii) Overlap, in which the central 
stimulus remains on screen during peripheral target presentation. Latency to shift attention to 
the peripheral stimulus in the Baseline vs Overlap conditions (disengagement) and in the Gap 
versus Baseline condition (facilitation) are key derived variables.   
 
Recording systems (see S1.5 for detailed descriptions per site) 
We wanted to align our protocols without requiring the purchasing of identical recording 
hardware at each site. This makes the study more cost-effective and easier to roll out on a 
larger scale in the future; builds on existing expertise within lab teams (rather than requiring 
them to learn new approaches); and provides a test of the generalizability of our findings 
across differences in hardware to which we expect them to be robust. However, it makes 
standardisation more technically challenging, and can raise the likelihood of site differences. 
To facilitate this, we developed a stimulus presentation framework, TaskEngine 
(https://sites.google.com/site/taskenginedoc/) to optimise the data quality and efficiency of 
acquisition of EEG and eye tracking data in multi-site studies. Briefly, this offers a number of 
advantages: 1) experimental stimuli were specified in centimetres and transformed to pixels 
at runtime by the framework. This ensured that the size and position of stimuli was constant 
for different screen sizes and screen resolutions across sites; 2) a unified system of event-
marking ensured compatibility between different EEG and eye tracking hardware. Events 
were defined for each experimental task, and passed to the framework which then sent them 
onward over whichever communication channel was in use (e.g. TCP/IP connection for EGI 
Netstation, serial port for Biosemi); 3) eye tracking data were acquired, managed and saved 
to disk by the framework. Timestamped eye tracking event markers were integrated into this 
data stream, ensuring that experimental events were identified by discrete points in time, 
rather than samples (since sampling rates differed between sites); 4) the framework produces 
a rich collection of QC and analysis scripts, exploiting the standardised data format of the 
stimulus presentation scripts. QC reports allow cross-site comparisons of data quality (see 
example in Figure S1). 
 
Infant behaviour management protocols 
Principles: Infant testing requires not only standardisation of equipment and experimental 
tasks, but also the broader environmental context including examiner behaviour. This is 
commonly neglected in the literature, but it could contribute critical variance across sites. To 
facilitate harmonisation, we held a week-long in-person meeting in London to discuss and 
agree on a standard series of lab protocols. The broad principles were applicable across the 
whole testing session, but some of the more detailed attention-getting protocols described 
below were only available during neurocognitive testing. Our protocols were built on the 
principles of standardization with flexibility. In infant testing it is essential to be responsive 
to the needs of the individual infant, because otherwise data quality will be poor.  Thus, we 
agreed a standard set of responses and priority order to infant fussiness; a standard set of 
instructions to parents; and a standard set of strategies for experimenters to use during testing 
that were included into Standardised Operating Procedures employed at all sites. Fuller 
details of testing practices for EEG and eyetracking are in the Supplementary Materials 
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(S1.1). Briefly, fussiness is defined as excessive motion, negative affect and avoidance 
behaviour that indicates the child is not enjoying participating in the experiment. Significant 
fussiness typically leads to poor quality or missing data. To maximise cross-site 
standardisation in responses to fussiness, we agreed a hierarchy of responses to maximise 
both data yield and participant comfort. Before the experiment, researchers asked parents to 
maximise their baby’s comfort by ensuring they were warm, fed, changed and seated 
comfortably. During the experiment, if a baby showed signs of fussiness (e.g. began to move 
more, show negative facial expressions, turn away from the screen) experimenters first 
addressed possible boredom by playing non-social ‘attention-getters’ through speakers. The 
presentation of these was automatically recorded in the data file, facilitating later comparison 
of the use of these strategies across sites. If that did not work, the examiner spoke to the 
baby; a manual code could insert this into the datafile. If fussiness continued, the parent was 
instructed to try (in this order) cuddling; holding hands; give baby something boring to hold 
(like a plastic teething ring); give baby a pacifier or snack; if all that did not work, a break 
was taken. If the parent wished to try again after the baby had calmed down, the experiment 
was resumed.  
 
Quality control  
Ongoing quality control was evaluated through monthly phone calls with site representatives 
during which data quality, testing practices and other issues were discussed. Further, a 
designated researcher with expertise in infant EEG and/or eyetracking supervised ongoing 
quality control checks of data as it was collected at each site. After collection, each data 
analysis pipeline includes further extensive quality control assessment. These will be analysis 
specific, but for example in EEG include rejection of segments where infants did not attend 
to stimuli, and segments containing artifact (e.g. motion, poor electrode contact).  
Each site collected session-level data on a Behavioural Observation Sheet. This 
included observations like changes in EEG cap position, infant state, any interference from 
parent or examiner, or any contextual variables that might affect data interpretation (like 
presence of an additional child). Further, the examiner reported their opinion of data validity 
for each modality. Specifically, data was marked as valid (can proceed to the next stage of 
processing and analysis); questionable (video of the session should be evaluated); or invalid 
(data should not progress to the next analytic stage). Data marked invalid was further 
assigned a qualitative category to denote the reason for invalidity. These were reasons to do 
with the child (e.g. would not wear the EEG cap, inattention, fussiness); reasons to do with 
the examiner (e.g. experimenter error); reasons to do with the parent (e.g. refused to 
participate, asked for session to stop, constantly interfered); technical error (e.g. computer 
crashed); or other.  These categories are critical to our ability to evaluate the reasons for data 
loss. Data marked valid or considered valid after review would move to the next step of the 
processing stream (at which further validity and inclusion judgements will be made). 
 Eye tracking data was acquired by the TaskEngine stimulus presentation framework, 
tagged with anonymised metadata and saved to disk. Offline preprocessing was performed in 
a custom-written pipeline in the following stages: 1) Data was loaded and IDs, age point and 
site metadata recorded; 2) The reference frame of the eye tracking data was transformed to 
harmonise the effects of screen size across sites. For sites with larger screens, stimuli were 
presented in a central ‘virtual window’ within the main screen. In these cases, the reference 
frame of the data was relative to the physical screen, this transformation made it relative to 
the virtual window; 3) Data was segmented by task and saved to disk; 4) Data quality metrics 
were extracted for all sessions and all tasks. 
 
Analysis approach 
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In the present manuscript, we report cross-site comparisons for our selected behavioural 
measures (Mullen Scales of Early Learning, Vineland Adaptive Behavior Scales). We 
compare online data quality assessments for EEG data across sites. We then present an in-
depth evaluation of cross-site data quality from our eyetracking battery. Briefly, the quality 
control metrics that we extract are: 1) Proportion of lost data samples (due to blinks, looking 
away, or the eye tracker failing to detect the eyes); 2) Flicker ratio – the proportion of pairs of 
adjacent samples that are both either present or absent capturing the degree to which the 
contact with the eyetracker fluctuates on a sample by sample basis; 3) Precision, calculated as 
the root mean square of the Euclidean distance between adjacent samples (in degrees) during 
fixations (defined as a series of adjacent samples with a velocity <1SD from the mean); 4) 
Accuracy, calculated as the mean offset of gaze from the centre of post-hoc calibration 
stimuli in degrees, separately for the x and y axes; 5) Mean distance of the infant’s eyes from 
the screen (distance along z-axis of track-box ), and from the centre of the track-box (3D) in 
mm; 6) Standard deviation of the distance of the infant’s eyes from the screen and centre of 
the track-box in mm.  
Finally, we analysed the gap/overlap task and extracted metrics related to data quality 
and its effect on an experimental task: 1) Number of valid trials; 2) Mean and SD of saccadic 
reaction time (SRT) from the baseline condition; 3) Mean and SD of the disengagement 
effect (overlap condition - baseline condition). Full data processing details are given in 
section S1.6 of Supplemental Material. Briefly, through automated scripts each trial was 
checked for data quality and correct behaviour on the part of the infant (moving directly from 
the central to the peripheral stimulus). Invalid trials were excluded, and the SRT to shift from 
the central to the peripheral stimulus was averaged across all remaining trials. All metrics 
were analysed with one-way ANOVA, with site as the independent factor, separately for each 
time point. Analyses were not corrected for multiple comparisons to avoid being overly 
conservative in detecting effects of site.  
 
 
Results 
 
Sites were broadly comparable in the maternal education status of enrolled families (Table 2). 
A chi-squared test on the number of parents with primary/ secondary (education to 16 years) 
vs tertiary education revealed marginally significant site effects (𝜒2 = 6.52, p = 0.09), though 
given the size of the sample the differences were not pronounced. Broadly, Table 2 indicates 
that parents had predominantly high levels of education. Of note, here we have 
operationalised socio-economic status as maternal education because this is a common metric 
to use in the US, and raw income bands are challenging to harmonise across countries. 
However, access to higher education also varies in cost and population take-up across Europe 
and may be influenced by factors distinct from those that influence higher education access in 
the US. We are actively exploring other options, such as computing ratios of incomes relative 
to poverty thresholds in each country.    
 
<< INSERT TABLE 2 ABOUT HERE>> 
 
Behavioural Assessment 
Scores on the Mullen Scales for Early Learning and the Vineland Adaptive Behaviour Scales 
both domain standard scores computed on the basis of US norms) were analysed using 
multivariate ANOVA with Site as an independent variable. Statistics are reported in Table 3 
(colour coded by effect size such that darker colours represent higher effect sizes), and data is 
visualised in SM Fig S2. Broadly, the pattern of data indicates substantial site effects on 
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Mullen scores. Site effects tended to be stronger for language measures (average hp2 across 
ages and RL, EL of 0.22; vs average hp2 across ages for motor [FM, GM] domains of .09), 
and stronger at older age points (average hp2 of 0.10 at 5m; 0.17 at 10m; 0.21 at 14m).   
 
<< INSERT TABLE 3 ABOUT HERE>> 
 
 
There were also site effects on Vineland scores, though they were generally smaller than 
Mullen scores (Table 4; visualised in SM Fig S2). Again, effect sizes were stronger at older 
age-points (mean hp2 of 0.04 at 5 months, 0.09 at 10 months and 0.11 at 14 months). In 
contrast to the Mullen, site effects were relatively stronger for daily living (mean hp2 across 
age 0.15) and motor domains (mean 0.11), and weaker for communication (mean 0.02) and 
socialisation (mean 0.03).  
 
<<INSERT TABLE 4 ABOUT HERE>> 
 
However, individual differences appeared equally stable over time at each site. Specifically, 
we conducted a series of ANCOVAs with 5-month Mullen domain scores as the covariates, 
site as an independent variable, and 10-month Mullen domain scores as the outcome 
variables (Table 5). We specified the model to test the main effects of site, 5-month Mullen 
domain scores and their interaction on 10-month Mullen domain scores. A significant 
interaction term would suggest that the sites significantly differed in the degree to which 5-
month Mullen scores predicted 10-month Mullen scores on that domain. Broadly, this was 
not the case; and in all cases 5-month Mullen domain scores significantly predicted 10m 
scores. The same was true from 10 to 14 months. The pattern of results was similar for 
Vineland scores with the exception of socialisation between 10 and 14 months, which 
showed less stability at Site D (F(1,116) = 1.49, p=0.23, hp2 = 0.013) than Sites A (F(1,58) = 
18.3, p<0.001, hp2 = 0.24) and B (F(1,116) = 1.49, p=0.23, hp2 = 0.013). Thus, although 
there were significant site differences in overall scores, there was broadly similar 
developmental continuity over time between sites.  
 
<<INSERT TABLE 5 ABOUT HERE>> 
 
EEG 
Because data has not yet been fully cleaned or processed, here we report the number of 
videos watched across sites, and the distribution of in-person validity judgements. This 
provides valuable information as to whether sites were able to collect sufficient data for 
analysis on this measure. Sites were broadly comparable in the percentage of children who 
provided valid data out of all the children in which data collection was attempted (Table 6). A 
chi-squared analysis showed no difference in the proportion of children with valid data by 
site at 5 months (𝜒2 = 2.06, p = 0.15); 10 months (𝜒2 = 2.65, p = 0.27); or 14 months (𝜒2 = 
2.98, p = 0.23). Within groups of children who watched at least one video (i.e. excluding 
children who refused to wear the sensor net/cap),  there were significant site effects for trial 
numbers at 5 months (F(1,146) = 7.13, p = 0.007, hp2 = 0.047) and 14 months (F(2,140) = 
3.47, p = 0.034, hp2 = 0.048) but with modest effect sizes; there were no significant effects at 
10 months (F(2,176) = 1.51, p = 0.23, hp2 = 0.017). The average number of one-minute 
segments watched was over 5 out of 6 at all age points and sites, which indicates that this 
measure was well tolerated and produced a low drop-out rate.  
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<<INSERT TABLE 6 ABOUT HERE>> 
 
Eyetracking 
Since data quality metrics were highly intercorrelated (Table S6) we ran a factor analysis 
with oblimin rotation on measures of post-hoc drift, proportion lost samples, flicker ratio, 
precision, and mean and variability of distance to the centre of both the screen and trackbox. 
Barlett’s test of Sphericity was highly significant (C2 = 6988.4, p < 0.001). Eigenvalues 
indicated that two components best explained the data (60.6% of variance) and Kaiser’s 
sampling adequacy was good (0.63). The two extracted components (with intercorrelation of 
0.13) roughly corresponded to Contact (with loadings of over .8 for post-hoc drift, proportion 
samples lost, and flicker ratio) and Position (with loadings > .75 for variability in distance 
from the screen and track box, and > .5 for mean distance; see Table S4). Full results for all 
quality control metrics are detailed in Table S5 and visualised in Figure 1 and Figure S3 of 
the Supplemental Material.  
 
<< INSERT FIGURE 1 ABOUT HERE>> 
 
A repeated-measures ANOVA on the two factors by site indicated that there were 
significant site effects at both 10 and 14 months (10 months: F(4,317) = 13.58, p <0.001, 
hp2=  = 0.15; 14 months: F(4,304) = 11.43, p <0.001, hp2=  = 0.13) and an interaction 
between the type of metric and site (10 months: F(4,317) = 3.86, p = 0.004, hp2=  0.046; 14 
months: F(4,304) = 3.31, p = 0.011, hp2=  = 0.042). The pattern of site effects indicated 
broadly that sites C and D had relatively better Contact than other sites {Contact at 10 
months: (B>D,C), (A>D,C), E, D, C; at 14 months (B>C,D),E,A,C,D} and that site D had 
relatively more optimal Positioning {10 months (C, A, E,B>D),D; 14 months: A>B,C,D), 
(E<D),B,C,D}.  There were no significant site effects or interactions with data quality at 5 
months (ps>0.05).  
Our most critical comparisons were on our experimental measure, the gap-overlap 
paradigm. The mean number of valid trials acquired on the gap-overlap paradigm differed 
between sites at 10 months (F(335)=2.61, p=.035, hp2= 0.03), with marginal significance at 5 
months (F(193)=2.92, p=.056, hp2= 0.03) and not at 14 months (F(322)=1.27, p=.28, hp2= 
0.02); broadly Site D had more valid trials than other sites. To understand the relation to data 
quality, we used ANCOVA with trial number as the dependent variable, the two measures of 
data quality as the predictor variables and included site as a between-subject variable as a 
main effect and in interaction with the metrics of data quality. As might be expected, this 
indicated a significant relation between better Contact (lower scores) and a greater number of 
valid trials at 10 months (F(1, 315) = 29.25, p <0.001, hp2 =0.089) and 14 months (F(1, 302) 
= 12.42, p =0.001, hp2 =0.041), with a significant interaction with Site at 10 months (F(1, 
315) = 3.19, p = 0.014, hp2 =0.041) but not 14 months: F(1, 302) = 1.22, p = 0.30, hp2 
=0.017)). This reflected stronger relations at Sites A and E (r2s = 0.28 and 0.35 respectively) 
vs the other sites (r2 < 0.15). Of note, the main effect of Site was not present after Contact 
was included in the model, indicating that this may explain the Site differences in trial 
numbers (F(1,301) = 0.71, p = 0.59). Positioning did not significantly relate to trial number at 
10 months (F(1, 315) = 0.85, p = 0.36, hp2 =0.003) but better Positioning related to more 
valid trials at 14 months F(1, 302) = 4.87, p = 0.028, hp2 =0.02 and this varied by Site 
(F(4,302) = 3.42, p = 0.009, hp2 = 0.045). This reflected strong relations at Site E (r2 = 0.31) 
but weaker relations elsewhere (r2s < 0.11). At 5 months, better Contact also related to a 
greater number of valid trials (Contact (F(1, 176) = 24.0, p <0.001, hp2 =0.13); but 
Positioning did not F(1, 176) = 0.042, p = 0.84, hp2 <0.001), with no interaction with Site (Fs 
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< 2.4, ps > 0.1, hp2< 0.03). Thus, as would be expected, better Contact at all ages (less 
flicker, fewer samples lost, less post-hoc drift) and better Positioning at 14 months (where 
infants are more mobile and perhaps more likely to move around) were associated with 
higher numbers of valid trials. This is consistent with the overall pattern of site effects, in that 
site D had more valid trials and generally better Contact and Positioning. 
The mean baseline saccadic reaction time (SRT) also differed between sites at all age 
points (Fs>2.507, ps<.042, hp2 >.03). Broadly, reaction times were slowest at site D and 
significantly faster at site A (Table S2). ANCOVAs as above indicated that at 5 months, 
neither metric of data quality related to SRTs (Contact F(1, 157) = 0.25, p = 0.62, hp2 
=0.002; F(1, 157) = 0.52, p = 0.47, hp2 =0.004). There was a significant relation between 
better Contact (lower scores) and shorter baseline SRT at 10 months (F(1, 303) = 6.23, p = 
0.013, hp2 =0.021) and 14 months (F(1, 291) = 5.92, p = 0.016, hp2 =0.021), with no 
significant interaction with Site at either age (although the effect size at 10 months was 
bigger than the main effect; F(1, 303) = 1.68, p = 0.16, hp2 =0.023; 14 months: F(1, 291) = 
.75, p = 0.56, hp2 =0.011)). However, the main effects of Site remained significant (10 
months: F(1, 303) = 4.22, p = 0.002, hp2 =0.055; 14 months F(1, 304) = 7.07, p = 0.008, hp2 
=0.047) with larger effect sizes, indicating that variation in Contact did not account for site 
variation in SRT. Positioning did not significantly relate to baseline SRT at either age (10 
months: F(1, 303) = 1.25, p = 0.27, hp2 =0.004; 14 months F(1, 291) = 3.49, p = 0.08, hp2 
=0.047). Thus, despite efforts to minimise the effect of data quality on task dependent 
variables (see S1.6), better Contact (less flicker, fewer samples lost, less post-hoc drift) 
remained weakly associated with faster baseline RTs in older infants (explaining 2-3% of the 
variance).  
Of note, simple correlations between Contact and shorter baseline SRT remained 
significant when number of valid trials was partialled out at 10 months (r(301)=.13, p = 
0.029) and 14 months (r(289)=.13, p = 0.049), indicating that the relation is not mediated by 
the number of trials obtained. The individual-level relations between better Contact and 
shorter baseline RT can be contrasted with the relatively better Contact and slower reaction 
times at site D. Thus, site differences in SRTs are unlikely to be simply related to site 
differences in data quality.  Nonetheless, covarying effects of Contact in future analysis 
involving basic SRTs could improve signal to noise ratio. 
Finally, we examined the primary dependent variable of interest from the gap task, the 
disengagement score. Disengagement scores are the difference between the baseline and 
overlap scores, and have been previously associated with later autism (c.f. Elsabbagh et al., 
2013). Critically, neither the mean disengagement scores, nor the standard deviation, 
significantly differed between sites (Fs<2.456, ps>.089, hp2 <.03).  Further, ANCOVAs as 
above revealed no significant relations with Contact (5 months: F(1, 157) = 0.68, p = 0.41, 
hp2 =0.005; 10 months: F(1, 303) = 0.004, p = 0.95, hp2 <0.001; 14 months F(1, 291) = 
0.937, p = 0.334, hp2 =0.003) or Positioning (5 months: F(1, 157) = 0.03, p = 0.86, hp2 
<0.001; F(1, 303) = 0.377, p = 0.54, hp2 =0.001; 14 months F(1, 291) = 0.542, p = 0.462, hp2 
=0.002) at any age. Thus, whilst scores on individual conditions may be influenced by data 
quality metrics, our primary metric of interest “disengagement” is robust to these lower level 
differences (Figure 2).  
 
<< INSERT FIGURE 2 ABOUT HERE>> 
 
Finally, we examined the specificity of individual differences in eyetracking data quality and 
core metrics over time at each site, to parallel behavioural analyses. Specifically, we 
conducted a series of ANCOVAs with each 5-month eyetracking variable as the covariates, 
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site as an independent variable, and 10-month eyetracking as the outcome variable, with and 
without our two data quality factors as additional covariates (Table 6). We specified the 
model to test the main effects of site, 5-month eyetracking scores and their interaction on 10-
month eyetracking scores. A significant interaction term would suggest that the sites 
significantly differed in the degree to which 5-month eyetracking scores predicted 10-month 
eyetracking scores on that domain. Broadly, this was not the case. Significant between-age 
stability from 5 to 10 and 10 to 14 months that did not vary by site was observed for baseline 
SRT; this remained significant after Contact was covaried (although this then revealed 
stronger developmental continuity at Site E). Interestingly, Contact itself showed some 
continuity between 5 and 10 and 10 and 14 months; the latter varied by site such that 
continuity was stronger at Sites A and E (the largest two sites). Disengagement showed 
significant stability between 10 and 14 months (and after data quality was covaried) but not 
earlier in development.  Position did not show stability in individual differences.  
 
<<INSERT TABLE 7 ABOUT HERE>> 
 
Discussion 
 
We report methods and harmonisation procedures for the Eurosibs multisite study of infants 
with high likelihood of developing ASD. The push towards ‘big science’ and the growing 
recognition of the need for more rigorously powered studies means that research groups are 
increasingly seeking to join together to build larger co-ordinated cohorts. This may be 
particularly important for prospective longitudinal studies of high likelihood populations, for 
which only a small proportion of infants may develop the clinical outcome of interest. 
However, multisite studies of young infants bring a unique set of challenges, perhaps 
particularly when using neurocognitive methods that involve advanced and often site-specific 
basic equipment. Our European context brings new challenges but also new opportunities 
because of the linguistic, cultural and contextual variance across sites. Testing whether our 
data is robust across substantial variance in these factors (including in experimental 
hardware) provides one way to triangulate evidence for the robust relation between predictor 
and outcome.  Further, if we wish our methods to extend to clinical practice in future work 
we must consider how harmonisation of measures across diverse recording sites can be 
achieved cost-effectively.  By sharing our strategy, we provide valuable information to others 
in the field about meeting the challenges of multisite infant research.  
 
Behavioural measures  
There were significant site effects on our observational behavioural measure (the Mullen 
Scales) that were greater at older age-points, and greatest for language scales. There are 
several potential explanations for this pattern. Firstly, it may be that a scale designed to 
measure acquisition of language in US infants does not work in the same way in a European 
context. Scores are compared to US norms that were generated from comparatively small 
samples, and it is likely that new country or language-specific norms are required. Indeed, 
norms differ between Dutch and US samples on the Bayley Scales of Infant and Toddler 
Development, a behavioural test comparable to the Mullen Scales (Steenis, Verhoeven, 
Hessen, & van Baar, 2015). Since official translations of our measures were largely 
unavailable, sites used in-house informal translations where necessary. This could also have 
added to cross-site variance in scores. Further, language development may proceed 
differently in different cultures; to tap comparable abilities items may need to be adjusted on 
a per-country basis (Pena, 2007). However, this poses other challenges for harmonisation and 
data pooling: adjusting scales based on how typically developing infants acquire language in 
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different cultures may not account for the fact that infants developing autism may have their 
own idiosyncratic acquisition patterns of word acquisition (Lazenby et al., 2016). Further, 
there were also heterogeneous language experiential profiles within some of our sites 
(particularly for site A and E), with exposure to additional languages very common. Using a 
measure specific to each infant’s primary language exposure would have been prohibitive 
and would have injected significant additional variance.  Within our study, some sites have 
datasets per age point that are larger than the original normative samples for some of the 
instruments we used. One analytic strategy may be to re-norm our cognitive scores within 
each site for later pooling (Mullen, 1995). Alternatively, we could explore patterns of data at 
the item level to see whether there are particular items that may be less specific to a particular 
language and more consistent across cultures (like features of communication); or use newly 
developed cross-linguistic tasks that take into account word frequency and age of acquisition 
for multiple languages (e.g. LITMUS-CLT, Haman et al., 2017). However, we think that the 
challenges of translating behavioural measures comparably (including those driven by the 
publishing industry; Bolte et al., 2016) is a further point in favour of neurocognitive measures 
that can better measure the more basic abilities that the child uses to learn whatever language 
to which they are exposed.  
Second, it may be that different testing practices across labs contributed to variance, 
despite our efforts to harmonise administration.  Within-US multisite studies do not appear to 
have experienced significant difficulties in achieving cross-site reliability (Olson, Gotham & 
Miller, 2012) but it may be that lab practices vary significantly more within Europe than 
within the US where there is likely greater mobility of the workforce between centres.  Thus, 
it may be necessary to increase the intensity of cross-site harmonisation procedures in future 
efforts, but this requires considerable resources. During the course of a study, if site effects 
emerge it is not necessarily the case that renewed efforts should be made to further harmonise 
procedures. Adjusting testing protocols during the course of a prospective longitudinal study 
is unwise. Since we do not know at the outset which children will develop ASD, we cannot 
ensure their even distribution across testing approaches. Further, changing testing protocols 
between timepoints could significantly impact longitudinal continuity. Our analyses suggest 
that within-site stability of developmental progression across age points was consistent across 
the consortium, indicating that our behavioural measures are likely valid measures of 
individual differences in developmental trajectory despite mean differences across locations. 
Thus, we chose to maintain current testing protocols at each site and deal with cross-site 
differences in later analysis. Third, it may be that there was true heterogeneity in the 
behavioural development of infants at each site. Sites did not significantly differ in maternal 
education but there was heterogeneity in the proportion of high-likelihood infants within each 
sample. There is also likely as-yet unmeasured heterogeneity in ASD outcome between the 
cohorts. This may contribute to site effects in behavioural assessments.  However, site effects 
on the parent-report Vineland measure were smaller, and more pronounced for motor skills 
and daily living than for communication skills. If site differences were due to true differences 
in behavioural profile, we would expect them to be consistent in domain profile across 
measures. Taken together, these observations indicate the challenges of using observational 
behavioural assessments of cognitive development in European samples, which are likely to 
themselves be less challenging than spreading research to other low and middle income 
countries.  
   
Neurocognitive measures 
Our neurocognitive measures showed promise in yielding relatively low initial attrition rates. 
For example, good quality EEG data was obtained from 70-100% of infants, with high 
comparability in attrition rates across sites. Given the EEG systems used ranged from 32 
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channel gel-based systems used at home to 128-electrode water-based electrodes in the lab, 
this similarity of acquisition rates is promising. Similarly, 90.1% of infants produced 
sufficient trials for analysis in the eyetracking gap-overlap paradigm. These relatively high 
rates of data inclusion provide critical evidence that neurocognitive measures are feasible for 
use in multisite infant studies, particularly since at each site these measures were embedded 
in much longer batteries. However, we did observe some site differences in low level 
parameters, such as the number of valid trials available for analysis. As for behavioural 
assessments, the range of possible explanations for this finding include true behavioural 
heterogeneity, differences in lab testing practice, and differences related to recording 
hardware (e.g. sampling rate differences).  
In contrast to behavioural assessments, our neurocognitive batteries provide far richer 
contextual data to aid interpretation of site effects. For example, our analyses and correlation 
tables (Figure S3) suggest that the number of valid trials suitable for analysis is primarily 
affected by raw data quality acquired by the eyetracker/eyetracker ‘contact’, including spatial 
error (post-hoc drift, precision) and temporal error (lost samples, flicker) at 5 and 10 months. 
We believe that this is an indication that our processing procedures for the gap task are 
effective at excluding trials with low basic data quality. Further, site differences in the 
number of valid trials obtained were only significant at 10 months, with infants at Site D 
providing the most valid trials for analysis, and also displaying the best Contact and 
Positioning. When Contact alone was taken into account, site effects were no longer 
significant and only Contact related significantly to valid trial number at this age. Thus, we 
can interpret site effects in trial numbers as resulting primarily from differences in the fidelity 
with which the infant’s eyes could be tracked, rather than how much they moved during the 
session.  Tracking fidelity may vary with hardware factors such as the model of eyetracker 
used: Sites C and D (with relatively better data quality) both used the TX300 eyetracker run 
at 300Hz (the latest model). In contrast, site differences in baseline SRTs could not be 
explained by differences in Contact. At all three ages, better Contact was associated with 
shorter baseline SRTs. However, whilst site D had broadly better Contact than other sites, 
SRTs at Site D were generally longer than at other sites. Site effects on SRTs also remained 
significant with increased effect sizes when Contact was covaried. Positioning did not relate 
significantly to SRTs. Thus, site differences in SRTs could not be explained by differences in 
basic data capture or in infant motion but could reflect true differences in emerging infant 
characteristics that will be further explored when longitudinal data is available.  
At 14 months, when infants are older and more mobile, the number of valid trials for 
analysis also become related to measures of infant Positioning (mean distance and variability 
within the trackbox or with respect to the screen). This potentially reflects inattention (e.g. 
see also Miller et al., 2016), such that infants who are less attentive move around more and 
are willing to spend less time engaging in the task.  Further exploration of metrics of infant 
motion during eyetracking paradigms and their interaction with neurocognitive data may 
contribute to our understanding of early-emerging behavioural profiles associated with later 
autism and ADHD.    
 Critically, we did not observe significant site effects on disengagement scores (as 
measured by overlap-baseline saccadic reaction times), our primary outcome variable for this 
task (Elsabbagh et al., 2013). This is highly promising since it suggests that whilst we were 
not able to achieve total harmonisation of basic saccade metrics (as evidenced by differences 
in baseline SRTs), the site differences were systematic enough that we were able to record 
harmonious condition differences. Disengagement scores were entirely independent of our 
quality control metrics (Table S6) indicating that our analytic pipelines were robustly able to 
generate putative biomarkers that are robust to variation in equipment and associated data 
quality. The one remaining correlation was between disengagement score and distance to the 
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screen at 14 months, such that infants seated further away from the screen saccade more 
rapidly. This may reflect the fact that distance from the screen affects the position of the 
peripheral stimulus on the retina, which would mean that a saccade takes longer to arrive at 
the peripheral stimulus. Having a precise measurement of this variable allows us to correct 
for this factor on a trial by trial basis. The disengagement scores are our final measure of task 
performance, extracted from the final stage of processing, which suggests that all of the 
preceding stages of data acquisition and processing were successful in allowing us to pool 
infant task data across multiple testing sites. Taken together, this demonstration of the 
potential of our pipelines to generate neurocognitive biomarkers that are robust to variation in 
both equipment and testing approaches is critical to their future deployment in clinical trial 
contexts, where standardisation of equipment across sites is impossible.    
 
Good scientific practice  
We recognise emerging debates in Psychology and other fields concerning reproducibility, p-
hacking, bias, and other questionable scientific practices. We have developed guidelines to 
maximise the quality of our scientific reporting. All measures were collected to Standardised 
Operating Procedures (available on request). All data analysis is accompanied by rigorous 
presentation of data quality metrics to ensure accurate interpretation. All analysis projects 
must be pre-specified on either a web-based resource such as Open Science Framework, or 
internally through our database. Any data access requires a pre-approved project form to 
discourage unreported analysis. All data analyses conducted will be reported, either as a 
publication or as an internal report that will be hosted on our website for other investigators 
to download should publication be difficult. At regular intervals we will publish accumulated 
summaries of these unpublished materials when they are considered sufficiently substantive. 
Datasets and analysis scripts used for published analyses will be archived centrally on the 
Eurosibs servers so that they can be readily accessed for replication work by other 
investigators. We also take a variety of active approaches to encourage replication and task-
sharing, which has led to a number of collaborative manuscripts (Haartsen et al., in press; 
Bussu et al., 2018; Tye, Bussu et al., in review; Braukmann et al., 2018) and the use of our 
TaskEngine framework by over 11 research groups in 8 countries. 
Data collection for our study is still ongoing, and thus primary output data is subject 
to an embargo period. However, once collection is complete and a period has elapsed to 
allow a primary data report from the consortium, our data will be made available to the 
research community through a limited (curated) open-access procedure. Considerable effort 
has gone into developing data sharing and access procedures that balance our responsibilities 
to both participants and the broader community. We recognise that data sharing is critically 
important to maximising the benefit of research; however, we also must consider the need to 
protect the confidentiality and personal health information of this sensitive group (who as 
minors do not consent for themselves, and for whom in some cases the diagnosis of ASD 
made through the research study is not necessarily accompanied by a community clinical 
diagnosis; thus, the infants and families themselves may not want to know that they meet 
criteria for ASD). In particular, our data has maximum value when data points are linked 
together (e.g. early EEG and later ASD outcome). This pseudonymised nature of the data 
makes open sharing particularly challenging because linked data-points increase in 
identifiability. Some measures require the use of video material, which being inherently 
identifiable requires even stricter governance. Currently, our consortium governs access to 
the data to ensure that end users confirm their compliance with all relevant data protection 
laws and have appropriate ethical permissions to perform relevant analyses. This operates via 
a project approval form that is considered by the Eurosibs Board, which consists of 
representatives from all involved sites. Projects are evaluated primarily on their consistency 
  18 
with the ethical principles families agreed to when they signed up to the study, and for 
overlap with other ongoing projects (in which case collaborations are suggested).  However, 
this procedure is reviewed on a rolling basis to optimise our value to the scientific 
community. 
 
Lessons learned 
During the creation of Eurosibs, we have encountered many challenges that provide 
important lessons for future work.  First, the time commitment and resources required for 
successful cross-site harmonisation should not be underestimated. We held a residential 
week-long training and harmonisation meeting, hosted several lab exchanges and site visits 
between labs within the consortium, and maintained standards through monthly phone calls 
and bi-annual in-person meetings. We also created standardised operating procedures for all 
our measures. The success of our consortium was in large part dependent on this high level of 
motivation. Despite this investment, site differences remained. One critical factor in infant 
testing is how to operationalise behaviour management. During our week-long residential 
meeting with core testers, we had lengthy discussions about strategies to deal with fussiness 
that revealed significant differences in existing lab practices. To address this, we agreed a 
harmonised protocol that attempted to balance flexibility to the needs of the infant with 
standardisation. For example, if infants started to become fussy (with increasing motion and 
negative affect) experimenters used a sequence of approaches that began with the use of 
attention getters coded and recorded through the scripts, moved through social strategies that 
minimised effects on data quality like cuddling or hand holding, and ended with taking a 
break. Broadly, this resulted in relatively comparable data quantity across sites. For example, 
all sites collected a per-baby average of over 5/6 EEG videos. However, there were some 
significant site differences in these metrics (albeit with small effect sizes). These were not 
consistent across age groups: no one site collected consistently larger quantities of data. 
Further, these differences did not appear to vary consistently with data quality such that it did 
not appear that (for example) one site was persisting with testing despite poor data quality 
longer than another. Thus, we do not see clear evidence for significant systematic site 
differences in how long testers persisted with the battery. However, the existence of some site 
differences may suggest that there were perhaps smaller fluctuations in testing practice that 
had less systematic and pervasive effects on data quantity; or that differences in the 
composition of samples at each site (e.g. the proportion of high-likelihood infants or the 
distance families travelled to the lab) could have affected data yields. These factors are hard 
to disentangle, but in future analyses exploring the relation between data quantity, quality and 
core dependent metrics will be critical.   
 Some factors we were unable to standardise given available resources, like hardware 
used for recording. However, heterogeneity can be a strength, because measures that are 
going to be used in a clinical context will have to be robust to substantially more 
environmental variation than is common between individual babylabs. In addition, measures 
derived from raw trial data and that index developmental change may remain robust in the 
face of lower-level site differences that are consistent across trial types. Multisite studies 
need to consider balancing the resources put into standardisation with the desirability of 
testing whether metrics are robust across natural variation between sites. In the latter case, 
collating as much information as possible about the nature of site differences can provide 
valuable information about possible factors influencing the validity of any markers obtained. 
Technical capacity is critically important. Our study required several technical 
innovations that were an essential component of success, and others that significantly reduced 
the investment in time required to handle the large quantities of data that we collected. 
Firstly, stimulus presentation can be extremely complicated for infant research due to a need 
  19 
to maintain high levels of experimental control for a population that cannot be instructed, 
rewarded, or reasoned with. The stimuli need to be engaging for infants, and tasks must 
usually be split up and interspersed with each other. Most commercial stimulus presentation 
packages are not flexible enough for these requirements, particularly for gaze-contingent eye 
tracking tasks, yet custom-written scripts are orders of magnitude more complex to develop 
and adjust, leading to far greater potential for error in how stimuli are presented and data 
collected. The stimulus presentation framework we used took considerable investment to 
develop and test but paid dividends as we developed more tasks and added more sites to the 
project. Pre-processing and analysis are considerably more complex in multi-site contexts 
and with large samples, and a pipelined approach to stages of processing is highly 
recommended. Reproducibility of processing steps is vital and should be in place at an early 
stage to allow rapid QC and feedback to testing sites. As with stimulus presentation, 
automation of data processing is a costly investment at the start of a project, but the use of 
general purpose transformations and algorithms to handle raw data allows for code to be 
reused across analyses. Larger samples justify a greater degree of automation, and manual 
checking is often not feasible, particularly for lengthy task batteries such as we employed. 
However, automated processes are often a blunt tool. We recommend using automated 
algorithms to inspect data and highlight outliers and potentially problematic datasets for 
manual inspection.  
 
Linguistic and cultural barriers 
Relative to a multi-site study within a country, we were further challenged by the 
considerable linguistic and cultural heterogeneity within our consortium. This is particularly 
challenging when using stimuli with social and vocal content.  Our naturalistic social videos 
included nursery rhymes that were selected to be relatively familiar to English-speaking 
infants. Using identical videos across contexts would have meant that only a proportion of the 
infants would be able to access the semantic content of the rhymes and would find them 
generally familiar at the linguistic level. Thus, we created new naturalistic social videos at 
every site, using local nursery rhymes that were selected to be as comparable as possible in 
the use of gesture, duration, and likely familiarity to the infant. At some sites the same 
nursery rhymes could be used (e.g. Sweden), whilst at others (e.g. Netherlands) we had to 
switch some of the rhymes because they were not commonly experienced. We also attempted 
to standardise the visual appearance, size and luminance of the movies as much as possible, 
whilst ensuring that their naturalistic quality was not compromised.  
For the remainder of our neurocognitive tasks, standardisation was much easier than 
for behavioural measures. The gap, PLR, and natural scenes batteries could all be used in the 
exact same format at every site. This is a considerable strength of using neurocognitive 
assessments. In contrast, our entire behavioural protocol had to be available in the child’s 
native language at each location. For some measures, this proved problematic (e.g. Bölte et 
al., 2016). For example, the Connor’s is not available in some European languages, and thus 
these sites used the ADHD-Rating Scale for assessment of ADHD symptoms. This creates 
challenges in pooling this data at the analytic stage. Manufacturers commonly refuse to allow 
questionnaires to be translated for particular research studies or require the cost of translation 
to be covered by the research study but the profits from selling the measure accrue to the 
company. This can severely limit the applicability of standardised measures in other cultures, 
since the availability of translations in European languages is relatively patchy (Bölte et al., 
2016). For other measures translations are available, but the data is compared to US norms 
(e.g. the Mullen). It is unclear whether these norms are applicable to other countries or in 
other languages. Indeed, a recent study indicated that the norms for the Bayley scales (a 
similar measure of infant development) do not operate in the same way in the Netherlands as 
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in the original US standardisation sample (Steenis et al., 2015).  This may be one explanation 
for the highly variable Mullen profiles seen in our current cohorts relative to other studies. 
Nonetheless, the relative ease of standardising most neurocognitive measures across sites 
relative to behavioural or questionnaire-based measures is a considerable strength of these 
methodologies. 
 
Future efforts 
We are currently working on the first data release from our cohort and expect our first wave 
of empirical papers to be completed in 2019. We are also building our program in a range of 
other ways. Consortium members are beginning studies of novel groups with elevated 
likelihood of atypical neurodevelopment (including infants with rare genetic syndromes, 
premature infants; and infants with older siblings with ADHD) using our common protocol. 
Using identical tasks across multiple groups will allow us to ask questions about the 
specificity or generalisability of our early markers to other routes to ASD and related 
neurodevelopmental disorders. We are also working to develop consensus across our 
consortium on key parameters for EEG and eyetracking processing that we will cascade 
through other studies in our lab, including the use of several of the same experiments and 
principles in the Longitudinal European Autism Project (Loth et al., 2017). We hope that this 
will create new levels of standardisation in these fields, which have sometimes lagged behind 
MRI in the widespread availability of processing pipelines. We will use a similar model to 
expand the use of core data quality metrics in developmental eyetracking research, which are 
commonly omitted from many studies in this area (though see e.g. Hessels et al., 2015; Wass 
et al., 2014). Our employment of a consistent system for categorising reasons for data loss in 
EEG studies (following international guidelines developed by Webb et al., 2013) also sets a 
new standard for the field. Finally, our study should provide a test case for the ability to 
translate ‘biomarkers’ across differences in hardware and software. This is critical for clinical 
utility, but there are surprisingly few demonstrations of the limits to which insights derived 
from one system can be generalised. This is particularly important for biomarkers derived 
from machine-learning approaches, which may be very likely to overfit features of the data 
that are system-specific.  
 
Conclusions  
The new era of ‘big science’ is coming to infancy research. Within the Eurosibs consortium, 
we have developed both technical and conceptual approaches to dealing with the challenges 
this brings in the context of prospective studies of early autism. We have learned many 
lessons and have continued to evolve our practices to optimise the quality of data collected by 
our network and look forward to continuing these efforts over the next decade. Core 
challenges remain in achieving high comparability in behavioral data across European 
countries with different cultures and languages, and research remains limited by overly-
prescriptive publication practices. Neurocognitive measures can be collected with high 
fidelity and with remarkably similar quality across sites; their great promise will be assessed 
once we have further knowledge of their clinical utility. Taken together, we hope that the 
Eurosibs study will provide a model for future data pooling efforts in early infancy research. 
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Figure 1: Eye tracking data quality metrics by age and site. Contact is a factor primarily 
composed of posthoc drift, proportion samples lost, and flicker ratio. Position is a factor 
primarily composed of variability in distance from the screen and track box. The bar charts 
represent mean and individual data; the histograms depict the proportion of children at each 
site within each bin.
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Figure 2: Gap disengagement scores by age and site. The bar charts represent mean and 
individual data; the histograms depicts the proportion of children at each site within each bin.  
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Table 1a: Participant gender balance and likelihood group for each site (%). HL = High 
Likelihood; LL = Low Likelihood.  
 
 
  HL-ASD LL 
Site Male Female Total Male Female Total 
A (129) 43%  35% 78%  14% 8% 23% 
B (51) 35% 27% 62%  22% 16% 38% 
C (25) 36% 24% 60% 28% 12% 40% 
D (72) 32% 38% 70% 18% 12% 30% 
E (100) 29% 26% 55% 24% 21% 45% 
 
Table 1b: Age in days by site and time-point 
 5 months 10 months 14 months 
A 177.0 (18.2) 
117-209 
319.9 (15.0) 
287-358 
450.7 (19.0) 
406-516 
B 160.5 (16.7) 
141-198 
307.8 (16.7) 
279-370 
429.9 (18.8) 
371-483 
C  314.9 (16.9) 
271-345 
433.9 (15.4) 
406-464 
D 160.9 (15.2) 
119-207 
311.0 (13.4) 
276-364 
433.5 (17.8) 
391-478 
E  314.3 (17.8) 
276-353 
437.2 (21.4) 
363-483 
Effect of site on age F(2,189) = 21.7, p < 
0.001, hp2 = 0.19 
F(4,374) = 7.66, p < 
0.001, hp2 = 0.076 
F(4,321) = 19.6, p < 
0.001, hp2  = 0.16 
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Table 2: Maternal education across sites. 
 
Maternal education (%) 
Site Primary Secondary Tertiary 
Undergraduate 
Tertiary 
Postgraduate 
A 0.8% 26.4% 41.6% 25.6% 
B 2% 33.3% 33.3% 17.5% 
C 0%  28%  24%  36% 
D 2.8% 18.1% 9.7% 45.8% 
E 0% 18% 38% 43% 
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Table 3: Site effects on the Mullen Scales of Early Learning, computed on domain 
standard scores. Darker colours represent higher effect sizes. Numbers in the first column 
represent the numbers of infants at each site who provided data for these analyses. 
 
 Mullen Scales of Early Learning 
  Gross motor Visual 
reception 
Fine motor Rec. Lang. Exp. Lang. 
5 
months 
A=91 
B=36 
D=65 
F(2, 192) = 
2.05, p = 
0.13, hp2 = 
0.021 
F(2, 192) = 
6.69, p = 
0.002, hp2 = 
0.066 
F(2, 192) = 
5.54, p = 
0.005, hp2= 
0.055 
F(2, 192) = 
29.58, p 
<0.001, hp2 = 
0.24 
F(2, 192) = 
21.52, p 
<0.001, hp2 = 
0.185 
10 
months 
A=119 
B=46 
C=14 
D=87 
E=61 
F(2, 327) = 
7.13, p 
<0.001, hp2 
= 0.081 
F(2, 327) = 
10.99, p 
<0.001, hp2 = 
0.12 
F(2, 327) = 
12.16, p 
<0.001, hp2 = 
0.13 
F(2, 327) = 
23.99, p 
<0.001, hp2 = 
0.23 
F(2, 356) = 
34.78, p 
<0.001, hp2 = 
0.30 
14 
months 
A=103 
B=41 
D=91 
E=60 
F(2, 295) = 
10.36, p 
<0.001, hp2 
= 0.096 
F(2, 295) = 
58.73, p 
<0.001, hp2 = 
0.38 
F(2, 295) = 
22.57, p 
<0.001, hp2 = 
0.19 
F(2, 295) = 
23.51, p 
<0.001, hp2 = 
0.195 
F(2, 295) = 
28.22, p 
<0.001, hp2 = 
0.23 
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Table 4: Site effects on the Vineland Adaptive Behaviour Scales, computed on domain 
standard scores. Darker colours represent higher effect sizes. Numbers in the first column 
represent the numbers of infants at each site who provided data for these analyses. 
 
 
 Vineland Adaptive Behavioural Scales 
  Communication Socialisation Motor Score Daily Living 
5 
months 
A=78 
B=32 
D=63 
F(2, 172) = 0.72, 
p = 0.49, hp2 = 
0.008 
F(2, 172) = 
0.45, p = 
0.64, hp2 = 
0.005 
F(2, 172) = 
0.057, p = 0.94, 
hp2 = 0.001 
F(2, 172) = 
12.59, p <0.001, 
hp2 = 0.13 
10 
months 
A=96 
B=40 
 
D=136 
 
F(2,272) = 3.74, p 
= 0.025, hp2 = 
0.027 
F(2,272) = 
7.36, p = 
0.001, hp2 = 
0.052 
F(2,272) = 
21.76, p <0.001, 
hp2 = 0.14 
F(2,272) = 21.97, 
p <0.001, hp2 = 
0.14 
14 
months 
A=65 
B=28 
D=117 
 
F(2,210) = 3.48, p 
= 0.033, hp2 = 
0.032 
F(2,210) = 
5.71, p = 
0.004, hp2 = 
0.052 
F(2,210) = 
23.93, p <0.001, 
hp2 = 0.19 
F(2,210) = 20.96, 
p <0.001, hp2 = 
0.17 
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Table 5: Association between Mullen and Vineland domain scores over time. Data 
reported are ANCOVAs with 5/10 month Mullen domain scores as the covariates, site as an 
independent variable, and 10/14-month Mullen domain scores as the outcome variables. 
Colours represent effect sizes, with darker shades being larger. 
 
 5 to 10 months 10 to 14 months 
 Predictor Predictor x Site Predictor Predictor x 
Site 
Mullen 
Gross Motor F(1,175) = 
25.87, p < 
0.001, hp2 = 
0.13 
F(2,175) = 0.57, 
p =0.84, hp2 = 
0.002 
F(1,265) = 
107.0, p< 0.001, 
hp2 = 0.29 
F(3,265) = 2.23, 
p = 0.085, hp2 = 
0.025 
Visual 
Reception 
F(1,175) = 8.01, 
p =0.005, hp2 = 
0.045 
F(2,175) = 0.41, 
p =0.67, hp2 = 
0.005 
F(1, 310) = 
22.31, p < 
0.001; hp2 = 
0.07 
F(3,310) = 0.29, 
p = 0.83, hp2 = 
0.003 
Fine Motor F(1,175) = 
17.73, p < 
0.001, hp2 = 
0.095 
F(2,175) = 1.42, 
p =0.25, hp2 = 
0.016 
F(1,309) = 
28.19, p < 
0.001, hp2 = 
0.09 
F(3,309) = 1.34, 
p = 0.26, hp2 = 
0.013 
Rec. Lang F(1,175) = 
11.51, p = 
0.001, hp2 = 
0.06 
F(2,175) = 1.07, 
p =0.35, hp2 = 
0.013 
F(1,310) = 31.9, 
p < 0.001, hp2 = 
0.096 
F(3,310) = 
0.093, p = 0.96, 
hp2 = 0.001 
Exp. Lang F(1,174) = 3.68, 
p =0.06, hp2 = 
0.021 
F(2,174) = 1.51, 
p =0.22, hp2 = 
0.018 
F(1,311) = 
42.20, p < 
0.001, hp2 = 
0.12 
F(3,311) = 1.12, 
p = 0.34, hp2 = 
0.011 
Vineland 
Communication F(1,151) = 16.7, 
p < 0.001, hp2 = 
0.10 
F(2,151) = 1.87, 
p = 0.16, hp2 = 
0.025 
F(1,207) = 51.3, 
p < 0.001, hp2 = 
0.2 
F(2,207) = 1.13, 
p = 0.33, hp2 = 
0.011 
Socialisation F(1,152) = 9.1, 
p = 0.003, hp2 = 
0.06 
F(2, 152) = 
0.92, p =0.4, 
hp2 = 0.012 
F(1,203) = 
16.42, p < 
0.001, hp2 = 
0.077 
F(2,203) = 4.34, 
p = 0.014, hp2 = 
0.042 
  35 
Motor  F(1,149) = 5.52, 
p = 0.02, hp2 = 
0.037 
F(2,149) = 0.12, 
p = 0.89, hp2 = 
0.002 
F(1,206) = 
60.86, p < 
0.001, hp2 = 
0.23 
F(2,206) = 2.54, 
p= 0.08, hp2 = 
0.025 
Daily Living F(1,157) = 5.80, 
p = 0.017, hp2 = 
0.037 
F(2,157) = 0.22, 
p = 0.81, hp2 = 
0.003 
F(1,205) = 
21.94, p < 
0.001, hp2 = 
0.099 
F(2,205) = 0.20, 
p = 0.82, hp2 = 
0.002 
 
Table 6: Validity and quantity of EEG data across sites where pre-processing available. 
 
 5 months 10 months 14 months 
 % Valid N trials 
watched 
% Valid N trials 
watched 
% Valid N trials 
watched 
A 
(n=89/116/
108) 
93% 5.7 (.1) 
2-6 
84% 5.2 (.1) 
1-6 
70% 5.3 (.14) 
2-6 
B 
(n=0/46/39) 
  89% 5.4 (.16) 
2-6 
74% 6 (0) 
6-6 
C 
(n=0/24/24) 
  100% 5.6 (.16) 
2-6 
88% 5.2 (.25) 
2-6 
D (n=66) 86% 5.3 (.13) 
3-6 
    
E       
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Table 7: Core eyetracking matrices over time. Data reported are ANCOVAs with 5/10-
month eyetracking scores as the covariates, site as an independent variable, and 10/14-month 
eyetracking scores as the outcome variables. Colours represent effect sizes, with darker 
shades being larger. 
 
 5 to 10 months 10 to 14 months 
 Predictor Predictor x Site Predictor Predictor x 
Site 
Eyetracking variable 
Gap overall 
trial N 
F(107) =5.60, p 
= .02, hp2 = .05 
F(107) =1.11, p 
=.30, hp2 =.011  
F(191) =2.87, p 
<.092, hp2 
=.015  
F(191) =1.42, p 
<.24, hp2 =.023  
With Contact at 
the two ages 
covaried 
F(89) = 7.92, p 
=.006, hp2 
=.087  
F(89) =6.92, p 
=.01, hp2 = 
0.077 (stronger 
site effects at 
Site E) 
F(164) =3.22, p 
=.075, hp2 = 
.021 
F(164) =1.54, p 
=.21, hp2 =.029  
Baseline SRT F(90) =8.52, p 
=0.004, hp2 = 
.09 
F(90) =1.03, p 
=.31, hp2 =.012  
F(175) = 53.76, 
p <.001, hp2 
=.24  
F(175) =1.27, p 
=.29, hp2 = .022  
With Contact at 
the two ages 
covaried 
F(77) =9.95, p 
=0.002, hp2 = 
.12 
F(77) =1.08, p 
=.30, hp2 =.015  
F(156) = 60.06, 
p <.001, hp2 
=.29  
F(156) =1.72, p 
=.17, hp2 = .034  
Disengagement F(90) =.33, p 
=.57, hp2 = .004 
F(88) =.003, p 
=.96, hp2 <.001  
F(175) =7.54, p 
=.007, hp2 = 
.043 
F(167) =1.01, p 
=.393, hp2 
=.018  
With Contact at 
the two ages 
covaried 
F(77) =.37, p 
=.54, hp2 = .005 
F(77) =.005, p 
=.95, hp2 <.001  
F(156) =10.19, 
p =.002, hp2 = 
.065 
F(156) =1.46, p 
=.23, hp2 =.029  
Contact F(94) =7.91, p 
=.006, hp2 = 
.081 
F(94) =.335, p 
=.56, hp2 =.004  
F(176) =20.46, 
p <0.001, hp2 = 
.11 
F(176) =4.65, p 
=.004, hp2 = 
.077 
Position F(94) =.85, p 
=.36, hp2 = .009 
F(94) =.32, p 
=.58, hp2 = .003 
F(175) =.66, p 
=.42, hp2 = .004 
F(175) =.98, p 
=.40, hp2 = .017 
 
 
 
 
